EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Cell Surface Markers of HIV Latency: Current Insights and Future Directions

Silvere D Zaongo iD, Shengquan Tang, Yanqiu Lu, Yaokai Chen

Reviews in Medical Virology · 2025

DOI: 10.1002/rmv.70077 ↗

At a glance

Übersichtsarbeit in Reviews in Medical Virology, 2025. Written by Silvere D Zaongo and 3 co-authors. Institution: Department of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China. Major MEDLINE topics: Virus Latency, HIV Infections, Biomarkers, HIV-1. 164 references. Funded by: Chongqing public health medical center research initiation fund, Chongqing technological innovation and application special project, Chongqing AIDS medical research center construction program.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The eradication of HIV remains challenging, primarily due to the persistence of latent HIV reservoirs within the human body that evade immune detection, even in the context of effective antiretroviral therapy (ART). These reservoirs, principally comprising CD4+ T‐cells, are characterised by their heterogeneity and dynamic nature, rendering their identification and targeted elimination ineffectual. This review examines recent advances in the identification of cell surface markers associated with HIV latency, emphasising their potential utility in the detection of HIV reservoir cells. Thus, markers such as CD2, CD20, CD30, CD32a, CD69, CD73, CD98, CD127, CD161, and VLA‐4, amongst others, are presented herein and evaluated based on their roles in HIV infection dynamics, latency maintenance, and reactivation potential. While promising candidates such as CD32a and PD‐1 demonstrate significant enrichment of HIV DNA and replication‐competent provirus, observations remain inconsistent across studies, highlighting the need for further research. Additionally, this review introduces P‐selectin glycoprotein ligand‐1 (PSGL‐1), a cell surface molecule extensively studied in relation to its role in inflammation, as a potential marker for HIV reservoir cells. By consolidating current evidence, this article revisits the intriguing realm of HIV reservoir cells and provides knowledge and a broader canvas for their identification via detection of specific cell surface molecules.

Subjects

MeSH terms (MEDLINE)

Virus LatencyHIV InfectionsBiomarkersHIV-1HumansCD4-Positive T-LymphocytesAntigens, CDMembrane Glycoproteins

Substances

BiomarkersP-selectin ligand proteinAntigens, CDMembrane Glycoproteins

Authors and institutions

  • Department of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China.

ORCID profiles: Silvere D Zaongo

Funding

  • Chongqing public health medical center research initiation fund
  • Chongqing technological innovation and application special project
  • Chongqing AIDS medical research center construction program
  • Chongqing disease prevention and public health research center construction program and the first batch of key disciplines on public health in Chongqing
  • Chongqing medical scientific research project-Joint project of Chongqing health commission and science and technology Bureau

Cite

APA

Zaongo, S. D., Tang, S., Lu, Y., & Chen, Y. (2025). Cell Surface Markers of HIV Latency: Current Insights and Future Directions. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70077

Vancouver

Zaongo SD, Tang S, Lu Y, Chen Y. Cell Surface Markers of HIV Latency: Current Insights and Future Directions. Reviews in Medical Virology. 2025. doi:10.1002/rmv.70077

BibTeX
@article{Zaongo2025,
  author = {Zaongo, Silvere D and Tang, Shengquan and Lu, Yanqiu and Chen, Yaokai},
  title = {Cell Surface Markers of HIV Latency: Current Insights and Future Directions},
  journal = {Reviews in Medical Virology},
  year = {2025},
  doi = {10.1002/rmv.70077}
}
Start for free →